Preventing organ rejection is a critical part of post-transplant care. This category includes medications commonly used to support immune system control and reduce the risk of rejection.

  • SIROASH 1 MG - 10 TABLET

    SIROASH 1 MG – 10 TABLET

    $8.80

    SIROASH 1 MG Capsules contain 1mg of Sirolimus, an immunosuppressant medication crucial for preventing organ rejection post-transplant and treating select cancers. Sirolimus inhibits mTOR pathway activity, effectively suppressing the immune response to prevent rejection and inhibiting cancer cell growth. This medication is often used alongside other immunosuppressants or anticancer drugs to optimize treatment outcomes.

    Add to cart
  • SIROMINE 1 MG - 10 TABLETS

    SIROMINE 1 MG – 10 TABLETS

    $9.90

    SIROMINE 1 MG Capsules contain 1mg of Sirolimus, an immunosuppressant medication that inhibits the body’s immune response to prevent organ rejection following transplantation. Sirolimus also exhibits antiproliferative properties, making it effective in treating certain types of cancer, including renal cell carcinoma and lymphangioleiomyomatosis (LAM). By blocking the action of mTOR (mammalian target of rapamycin) pathway, Siromine helps control cell growth and proliferation. This medication is typically used in combination with other immunosuppressants or anticancer drugs as part of a comprehensive treatment regimen.

    Add to cart